Semi-inmersive Virtual Reality on Upper Limb in Multiple Sclerosis

Sponsor
Universidad Rey Juan Carlos (Other)
Overall Status
Recruiting
CT.gov ID
NCT04171908
Collaborator
(none)
15
1
2
19.9
0.8

Study Details

Study Description

Brief Summary

Video games based on VR technology are emerging as valid tools used in neurorehabilitation for patients with neurological disorders, and as a low cost and easily accepted adjunct to traditional therapy. Standard games such as the Nintendo Wii, Playstation Move and Kinect plus XBOX 360 have been used in PD rehabilitation. However, often these are either too difficult for patients or the games progress too quickly, failing to provide impairment-focused training or specifically address patients' needs [10]. Therefore, it is necessary to develop specific serious games for PD patients. Serious games are defined as games designed for a primary purpose other than that of pure entertainment, and which promote learning and behavior changes for PD patients. In this context, new low-cost markerless devices have emerged, such as Nintendo Switch Joy-Con ®, which uses a sensor that captures the movement of the patient's forearms and hands without the need to place sensors or devices on the body. This generates a virtual image of the upper limbs on a computer screen and the patient is prompted to perform movements according to the functional task proposed. This system presents important advantages over other motion capture systems, namely thanks to its portability, ease of use, commercial availability, low cost and non-invasive nature. However, evidence is lacking that supports the therapeutic use of Nintendo Switch Joy-Con in the treatment of upper limb (UL) motor disorders in EM.

Condition or Disease Intervention/Treatment Phase
  • Other: Conventional therapy
  • Other: Nintendo Switch Joy-Con
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effects of a Semi-inmersive Virtual Reality Training Program on Muscle Strength, Coordination, Fatigue, Functionality and Quality of Life in Patients With Multiple Sclerosis
Actual Study Start Date :
Nov 12, 2019
Anticipated Primary Completion Date :
Jun 11, 2021
Anticipated Study Completion Date :
Jul 11, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Conventional therapy

Conventional Physical therapy for the upper limb

Other: Conventional therapy
Conventional Physical therapy for the upper limb

Experimental: Nintendo Switch Joy-Con plus conventional therapy

Conventional Physical therapy for the upper limb plus Nintendo Switch Joy-Con

Other: Nintendo Switch Joy-Con
Conventional Physical therapy for the upper limb plus Nintendo Switch Joy-Con

Outcome Measures

Primary Outcome Measures

  1. Jamar [8 weeks]

    Hand-held dynamometer: it is an instrument to measure the maximumisometric strength of the hand and forearm muscles. It consists of a sealed hydraulic system with adjustable hand spacing that measures hand grip force. The strength reading can be viewed as pounds or kilograms.Thedynamometer is used for testing the hand grip force and for tracking the grip strength improvements during rehabilitation.

  2. Box and blocks [8 weeks]

    Coordination test: to measure unilateral gross manual dexterity in both the less and more affected side. The Box and blocks consists of moving the maximum number of blocks from one compartment of a box to another, one by one, within one minute. The Box and blocks is a quick, simple, and reliable measurement of manual dexterity. Its administration procedure is standardized and its validity has been shown in elderly subjects with upper limb disability

  3. The Purdue Pegboard Test [8 weeks]

    Motricity: to assess coordination, speed of movement and fine motor dexterity. The The Purdue Pegboard Test features a board with two columns with 25 holes each and a specific number of pins, washers and collars placed in four containers across the top of the board. The test consists of inserting as many pins as possible in three distinct phases, with a time limit of 30 s for each. First, the test is performed with the less affected side, then with the more affected side, then with both hands at the same time and, finally, an assembly test is performed (60 s). The number of pins inserted is subsequently recorded.

  4. Nine Hole Peg Test [8 weeks]

    Motricity: It is a hand function test, which consists of a plastic peg board (25.0 cm × 12.7 cm × 2.3 cm) with nine holes (2.54 cm between the holes) and nine pegs (3.2 cm long, 0.64 cm wide). The participant had to put the nine pegs in the peg board as fast as possible, one at the time with one hand only, and remove them again. The test was performed two times per hand, with the non-affected hand first. The time it takes to fulfill the second trial with the more-affected hand was used for the analysis

Secondary Outcome Measures

  1. The Client Satisfaction Questionnaire [after 8 weeks of treatment]

    The Client Satisfaction Questionnaire was used to evaluate the satisfaction of health service users for both groups. This is a self-administered post-treatment questionnaire, comprising eight items which evaluate the level of satisfaction regarding the care and quality of the service received and the level of fulfillment of the patient's expectations regarding the treatment administered. The total score of the questionnaire is 32 points, with higher values meaning higher satisfaction with the treatment received

  2. Adherence [after 8 weeks of treatment]

    The attendance rate (%) for therapy sessions (compliance) will be registered

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of MS according to McDonald's criteria.

  • Assessment on the Kurtzke Scale of the State of Multiple Sclerosis Disability (EDSS) with a score between 1.0 and 7.5.

  • Stable medical treatment for at least six months prior to the intervention.

  • Muscle tone in the upper extremities not greater than 2 points (moderate hypertonia, increased muscle tone during most of the arc of movement, but the affected part can easily be moved passively) on the modified Ashworth Scale.

  • Score less than or equal to 4 points in the section ¨Piramidal Function¨ of the functional scale of the EDSS.

  • Absence of cognitive impairment, with the ability to understand the instructions and obtain a score equal to or greater than 24 in the Minimental Test.

  • Score equal to or less than 2 points in the section ¨Functions Mental¨ of the EDSS.

Exclusion Criteria:
  • Diagnosis of another neurological disease or musculoskeletal disorder other than MS.

  • Diagnosis of any cardiovascular, respiratory or metabolic disease.

  • Other conditions that may interfere with this study, having suffered an exacerbation or hospitalization in the last 3 months before starting the protocol of assessment, or during the therapeutic intervention process.

  • Having received a steroid cycle, intravenously or orally, 6 months before the start of the assessment protocol and within the intervention period of study duration.

  • Having received treatment with botulinum toxin in the six months prior to the start of the study.

  • Presence of uncorrected visual disturbances through eye devices.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Roberto Cano de la Cuerda Alcorcón Madrid Spain 28922

Sponsors and Collaborators

  • Universidad Rey Juan Carlos

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Josue Fernandez Carnero, Full proffesor, Universidad Rey Juan Carlos
ClinicalTrials.gov Identifier:
NCT04171908
Other Study ID Numbers:
  • Virtual Arms-EM
First Posted:
Nov 21, 2019
Last Update Posted:
Apr 9, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 9, 2021